Do you want to read an article? Please log in or register.
International Expert Consensus on Switching Platelet P2Y12 Receptor-Inhibiting Therapies
Therapy and Intervention
Related content
Heart, Artery and Coronary DiseasesThrombosis and StrokeTherapy and Intervention
Benefit of Switching Dual Antiplatelet Therapy After Acute Coronary Syndrome According to On-Treatment Platelet Reactivity: The TOPIC-VASP Pre-Specified Analysis of the TOPIC Randomized Study
JACC Cardiovasc Interv.
Deharo P, Quilici J, Camoin-Jau L, Johnson TW, Bassez C, Bonnet G, Fernandez M, Ibrahim M, Suchon P, Verdier V, Fourcade L, Morange PE, Bonnet JL, Alessi MC, Cuisset T
doi: 10.1016/j.jcin.2017.08.044.
Heart, Artery and Coronary DiseasesThrombosis and StrokeTherapy and Intervention
Benefit of switching dual antiplatelet therapy after acute coronary syndrome: the TOPIC (timing of platelet inhibition after acute coronary syndrome) randomized study
Eur Heart J.
Cuisset T, Deharo P, Quilici J, Johnson TW, Deffarges S, Bassez C, Bonnet G, Fourcade L, Mouret JP, Lambert M, Verdier V, Morange PE, Alessi MC, Bonnet JL
doi: 10.1093/eurheartj/ehx175.
Heart, Artery and Coronary Diseases
International Expert Consensus Document on Takotsubo Syndrome (Part II): Diagnostic Workup, Outcome, and Management
Eur Heart J.
Ghadri JR, Wittstein IS, Prasad A, Sharkey S, Dote K, Akashi YJ, Cammann VL, Crea F, Galiuto L, Desmet W, Yoshida T, Manfredini R, Eitel I, Kosuge M, Nef HM, Deshmukh A, Lerman A, Bossone E, Citro R, Ueyama T, Corrado D, Kurisu S, Ruschitzka F, Winchester D, Lyon AR, Omerovic E, Bax JJ, Meimoun P, Tarantini G, Rihal C, Y-Hassan S, Migliore F, Horowitz JD, Shimokawa H, Lüscher TF, Templin C; International Experts:, Bax JJ, Bossone E, Cammann VL, Citro R, Corrado D, Crea F, Desmet W, Eitel I, Galiuto L, Ghadri JR, Lüscher TF, Lyon AR, Manfredini R, Meimoun P, Migliore F, Nef HM, Omerovic E, Ruschitzka F, Tarantini G, Templin C, Y-Hassan S, Deshmukh A, Lerman A, Prasad A, Rihal C, Sharkey S, Winchester D, Wittstein IS, Akashi YJ, Dote K, Kosuge M, Kurisu S, Shimokawa H, Ueyama T, Yoshida T, Horowitz JD
doi: 10.1093/eurheartj/ehy077.
Heart, Artery and Coronary DiseasesHeart Failure
International Expert Consensus Document on Takotsubo Syndrome (Part I): Clinical Characteristics, Diagnostic Criteria, and Pathophysiology
Eur Heart J.
Ghadri JR, Wittstein IS, Prasad A, Sharkey S, Dote K, Akashi YJ, Cammann VL, Crea F, Galiuto L, Desmet W, Yoshida T, Manfredini R, Eitel I, Kosuge M, Nef HM, Deshmukh A, Lerman A, Bossone E, Citro R, Ueyama T, Corrado D, Kurisu S, Ruschitzka F, Winchester D, Lyon AR, Omerovic E, Bax JJ, Meimoun P, Tarantini G, Rihal C, Y-Hassan S, Migliore F, Horowitz JD, Shimokawa H, Lüscher TF, Templin C; International Experts:, Bax JJ, Bossone E, Cammann VL, Citro R, Corrado D, Crea F, Desmet W, Eitel I, Galiuto L, Ghadri JR, Lüscher TF, Lyon AR, Manfredini R, Meimoun P, Migliore F, Nef HM, Omerovic E, Ruschitzka F, Tarantini G, Templin C, Y-Hassan S, Deshmukh A, Lerman A, Prasad A, Rihal C, Sharkey S, Winchester D, Wittstein IS, Akashi YJ, Dote K, Kosuge M, Kurisu S, Shimokawa H, Ueyama T, Yoshida T, Horowitz JD
doi: 10.1093/eurheartj/ehy076.
Heart, Artery and Coronary DiseasesHeart Failure
2017 ACC Expert Consensus Decision Pathway on the Management of Mitral Regurgitation: A Report of the American College of Cardiology Task Force on Expert Consensus Decision Pathways
J Am Coll Cardiol.
O'Gara PT, Grayburn PA, Badhwar V, Afonso LC, Carroll JD, Elmariah S, Kithcart AP, Nishimura RA, Ryan TJ, Schwartz A, Stevenson LW
doi: 10.1016/
Heart, Artery and Coronary Diseases
Pharmacodynamics, pharmacokinetics, and safety of single-dose subcutaneous administration of selatogrel, a novel P2Y12 receptor antagonist, in patients with chronic coronary syndromes
Eur Heart J.
Storey RF, Gurbel PA, Ten Berg J, Bernaud C, Dangas GD, Frenoux JM, Gorog DA, Hmissi A, Kunadian V, James SK, Tanguay JF, Tran H, Trenk D, Ufer M, Van der Harst P, Van't Hof AWJ, Angiolillo DJ
doi: 10.1093/eurheartj/ehz807.
Pharmacodynamic Effects of Switching From Ticagrelor to Clopidogrel in Patients With Coronary Artery Disease: Results of the SWAP (Switching Antiplatelet Therapy)-4 Study
Circulation.
Franchi F, Rollini F, Rivas Rios J, Rivas A, Agarwal M, Kureti M, Nagaraju D, Wali M, Shaikh Z, Briceno M, Nawaz A, Moon JY, Been L, Suryadevara S, Soffer D, Zenni MM, Bass TA, Angiolillo DJ
doi: 10.1161/CIRCULATIONAHA.
Myocardial Infarction
Platelet Inhibition, Endothelial Function, and Clinical Outcome in Patients Presenting With ST-Segment-Elevation Myocardial Infarction Randomized to Ticagrelor Versus Prasugrel Maintenance Therapy: Long-Term Follow-Up of the REDUCE-MVI Trial
J Am Heart Assoc.
van der Hoeven NW, Janssens GN, Everaars H, Nap A, Lemkes JS, de Waard GA, van de Ven PM, van Rossum AC, Escaned J, Mejia-Renteria H, Ten Cate TJF, Piek JJ, von Birgelen C, Valgimigli M, Diletti R, Riksen NP, Van Mieghem NM, Nijveldt R, van Leeuwen MAH, van Royen N
doi: 10.1161/JAHA.119.014411.
Myocardial InfarctionTherapy and Intervention
Platelet Inhibition with Cangrelor and Crushed Ticagrelor in Patients with ST-Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention: Results of the CANTIC Study
Circulation.
Franchi F, Rollini F, Rivas A, Wali M, Briceno M, Agarwal M, Shaikh Z, Nawaz A, Silva G, Been L, Smairat R, Kaufman M, Pineda A, Suryadevara S, Soffer D, Zenni MM, Bass TA, Angiolillo DJ
doi: 10.1161/